Drug companies have overlooked patients who don’t respond to HIV meds

There are tens of thousands of these non-responders in the U.S., whose low CD4 numbers put them at much higher risk of heart attacks, stroke, cancers, secondary infections such as tuberculosis, and death. And yet, drug companies and researchers aren’t actively pursuing new treatments that would boost their immunity, leaving people like Vergel feeling neglected.

Read More

ABIA concerned after the exoneration of HIV/AIDS and STIs Department Director

In view of recent changes in the Ministry of Health’s Department of Surveillance, Prevention and Control of STIs, HIV and Viral Hepatitis of the Ministry of Health, ABIA wishes to express concerns regarding the sustainability STIs and HIV/AIDS control policies.

Read More

HIV in the Philippines: why it must act fast to control growing epidemic, advocacy groups lead the way

While many countries, including in Southeast Asia, have seen a fall in new HIV infections, the Philippines has seen a sharp rise.
Bureaucracy, a conservative society and the Catholic Church are the main stumbling blocks to effective action.

Read More

Elizabeth Warren is trying to break up Big Pharma “cartels” by letting the government make generic drugs

Democratic Sen. Elizabeth Warren, who’s widely expected to run for president in 2020, introduced a bold piece of legislation Tuesday that seeks to break up generic drug “cartels” by allowing the U.S. government to manufacture its own drugs.

Read More


Publications


Infographic

AIDS in the world

AIDS in the world

See the trajectory
of the AIDS epidemic.

Newsletter

Newsletter

Your Name (required):


Your Email (required)

Please fill all widget settings!

Facebook